Adrian JohnsonTLDR:
- Health First has invested in painkilling technology to ease patients’ recovery after major surgeries.
- The cryoSPHERE technology has been used in minimally invasive valve replacement procedures with great success in managing postoperative pain without the need for opioid prescriptions.
In a recent article by Space Coast Daily, it was reported that Health First has made a significant investment in painkilling technology to help ease patients’ recovery after major surgeries. The company’s Cardiothoracic Surgeon, Dr. Matthew Campbell, has been using AtriCure’s cryoSPHERE technology in minimally invasive valve replacement procedures at the Heart Center at Holmes Regional Medical Center.
The cryoSPHERE system works by targeting and freezing a nerve bundle between the ribs called the intercostal, which deadens pain receptors in the nerves. This technology has been successful in managing postoperative pain without the need for opioid prescriptions. Dr. Campbell stated that this technology has eliminated the need for opioid pain medications, which are often a predictor of addiction for patients.
Health First has seen a significant improvement in postoperative pain control with the use of cryoSPHERE, making it a valuable addition to their minimally invasive protocols. The company recently celebrated its 1,000th transcatheter aortic valve replacement procedure and received 3 stars from the Society of Thoracic Surgeons for its patients’ outcomes.
This investment in painkilling technology highlights Health First’s commitment to improving patient care and recovery outcomes after major surgeries. The success of the cryoSPHERE technology in managing postoperative pain without the use of opioids is a significant development in the field of pain management and could have far-reaching benefits for patients undergoing similar procedures.